| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 236 |
| Opened positions | 40 |
| Closed positions | 25 |
| Increased positions | 70 |
| Reduced positions | 86 |
| 13F shares | Current |
|---|---|
| Total value | 1.94 tn |
| Total shares | 79.06 mm |
| Total puts | 49.20 k |
| Total calls | 108.10 k |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| Valor IV Pharma | 11.22 mm | $0.00 |
| Valor Management | 11.22 mm | $448.72 bn |
| Fund Trust Marshman II | 10.65 mm | $385.04 mm |
| BlackRock | 5.66 mm | $226.24 bn |
| FMR | 5.23 mm | $209.15 bn |
| Vanguard | 3.47 mm | $138.85 bn |
| venBio Global Strategic Fund II | 2.74 mm | $0.00 |
| Vivo Capital | 2.61 mm | $104.25 bn |
| Vivo Capital VIII | 2.57 mm | $0.00 |
| HBM Healthcare Investments | 2.15 mm | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jan 25 | Sandip Kapadia | Common Stock | Sell | Dispose S | No | Yes | 38.0548 | 1,775 | 67.55 k | 0 |
| 27 Jan 25 | Jeffrey Dierks | Common Stock | Sell | Dispose S | No | Yes | 38.024 | 1,629 | 61.94 k | 0 |
| 25 Jan 25 | Andrew Serafin | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,400 | 0.00 | 10,400 |
| 25 Jan 25 | Andrew Serafin | Stock Option Common Stock | Grant | Acquire A | No | No | 38.01 | 36,500 | 1.39 mm | 36,500 |
| 25 Jan 25 | Sandip Kapadia | RSU Common Stock | Grant | Acquire A | No | No | 0 | 18,900 | 0.00 | 18,900 |
| 25 Jan 25 | Sandip Kapadia | Stock Option Common Stock | Grant | Acquire A | No | No | 38.01 | 66,250 | 2.52 mm | 66,250 |
| 25 Jan 25 | Jeffrey M. Dayno | RSU Common Stock | Grant | Acquire A | No | No | 0 | 52,000 | 0.00 | 52,000 |
| 25 Jan 25 | Jeffrey M. Dayno | Stock Option Common Stock | Grant | Acquire A | No | No | 38.01 | 180,000 | 6.84 mm | 180,000 |
| 25 Jan 25 | Jeffrey Dierks | RSU Common Stock | Grant | Acquire A | No | No | 0 | 13,450 | 0.00 | 13,450 |
| 25 Jan 25 | Jeffrey Dierks | Stock Option Common Stock | Grant | Acquire A | No | No | 38.01 | 47,200 | 1.79 mm | 47,200 |
